+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

Pipeline of Claudin 18.2-Targeted Immunotherapy - Product Thumbnail Image

Pipeline of Claudin 18.2-Targeted Immunotherapy

  • Report
  • December 2025
  • Global
From
From
From
DLL3-Targeted Immunotherapy: a Competitor Analysis - Product Thumbnail Image

DLL3-Targeted Immunotherapy: a Competitor Analysis

  • Report
  • December 2025
  • Global
From
From
From
Pipeline of KLK2-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of KLK2-Targeted Immunotherapies

  • Report
  • December 2025
  • Global
From
From
From
From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
From
From
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more